News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dainippon Pharmaceutical, Sumitomo Pharmaceuticals Co. Ltd. And Ono Pharmaceutical Company, Ltd. To Enter Into Joint Development And Marketing Agreement For Limaprost Alfadex, Oral PGE1 Derivative



12/7/2005 11:48:57 AM

Tokyo (JCN) Dec 6, 2005 - Ono Pharmaceutical and Dainipopn Sumitomo Pharma jointly announced on December 6 that they have singed a joint development and marketing agreement for limaprost alfadex, an oral prostaglandin E1 derivative indicated for the treatment of peripheral circulatory disturbance.

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES